Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

BioAge Labs (BIOA) Equity Average (2024 - 2025)

BioAge Labs (BIOA) has disclosed Equity Average for 2 consecutive years, with $274.8 million as the latest value for Q4 2025.

  • Quarterly Equity Average fell 13.72% to $274.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $274.8 million through Dec 2025, down 13.72% year-over-year, with the annual reading at $297.6 million for FY2025, N/A changed from the prior year.
  • Equity Average hit $274.8 million in Q4 2025 for BioAge Labs, down from $286.1 million in the prior quarter.
  • In the past five years, Equity Average ranged from a high of $318.4 million in Q4 2024 to a low of -$191.3 million in Q2 2024.